Idera Pharmaceuticals

$1.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.74%) Today
+$0.01 (+0.75%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell IDRA and other stocks, options, and ETFs commission-free!

About IDRA

Idera Pharmaceuticals, Inc. Common Stock, also called Idera Pharmaceuticals, is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications.

CEO
Vincent J. Milano
Employees
32
Headquarters
Exton, Pennsylvania
Founded
1989
Market Cap
54.95M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
5.13M
High Today
$1.41
Low Today
$1.31
Open Price
$1.33
Volume
5.84M
52 Week High
$6.14
52 Week Low
$1.22

IDRA Earnings

-$0.46
-$0.23
-$0.01
$0.22
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Apr 29, After Hours

You May Also Like

FNK
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure